Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

829 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glucagon-like peptide 1--a cardiologic dimension.
Treiman M, Elvekjaer M, Engstrøm T, Jensen JS. Treiman M, et al. Among authors: jensen js. Trends Cardiovasc Med. 2010 Jan;20(1):8-12. doi: 10.1016/j.tcm.2010.02.012. Trends Cardiovasc Med. 2010. PMID: 20685571 Review.
[Glucagon-like peptide-1: a cardiological perspective].
Elvekjaer M, Engstrøm T, Jensen JS, Treiman M. Elvekjaer M, et al. Among authors: jensen js. Ugeskr Laeger. 2010 Oct 11;172(41):2822-6. Ugeskr Laeger. 2010. PMID: 20961501 Review. Danish.
Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.
Lønborg J, Kelbaek H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Treiman M, Jensen JS, Engstrøm T. Lønborg J, et al. Among authors: jensen js. Circ Cardiovasc Interv. 2010 Feb 1;3(1):34-41. doi: 10.1161/CIRCINTERVENTIONS.109.905521. Epub 2010 Jan 26. Circ Cardiovasc Interv. 2010. PMID: 20118154 Clinical Trial.
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T. Lønborg J, et al. Among authors: jensen js. Eur Heart J. 2012 Jun;33(12):1491-9. doi: 10.1093/eurheartj/ehr309. Epub 2011 Sep 14. Eur Heart J. 2012. PMID: 21920963 Clinical Trial.
Value of Myocardial Perfusion Assessment With Coronary Computed Tomography Angiography in Patients With Recent Acute-Onset Chest Pain.
Sørgaard MH, Linde JJ, Kühl JT, Kelbæk H, Hove JD, Fornitz GG, Jørgensen TBS, Heitmann M, Kragelund C, Hansen TF, Abdulla J, Engstrøm T, Jensen JS, Wiegandt YT, Høfsten DE, Køber LV, Kofoed KF. Sørgaard MH, et al. Among authors: jensen js. JACC Cardiovasc Imaging. 2018 Nov;11(11):1611-1621. doi: 10.1016/j.jcmg.2017.09.022. Epub 2017 Dec 13. JACC Cardiovasc Imaging. 2018. PMID: 29248654 Free article. Clinical Trial.
Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial.
Galløe AM, Thuesen L, Kelbaek H, Thayssen P, Rasmussen K, Hansen PR, Bligaard N, Saunamäki K, Junker A, Aarøe J, Abildgaard U, Ravkilde J, Engstrøm T, Jensen JS, Andersen HR, Bøtker HE, Galatius S, Kristensen SD, Madsen JK, Krusell LR, Abildstrøm SZ, Stephansen GB, Lassen JF; SORT OUT II Investigators. Galløe AM, et al. Among authors: jensen js. JAMA. 2008 Jan 30;299(4):409-16. doi: 10.1001/jama.299.4.409. JAMA. 2008. PMID: 18230778 Clinical Trial.
Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial.
Rasmussen K, Maeng M, Kaltoft A, Thayssen P, Kelbaek H, Tilsted HH, Abildgaard U, Christiansen EH, Engstrøm T, Krusell LR, Ravkilde J, Hansen PR, Hansen KN, Abildstrøm SZ, Aarøe J, Jensen JS, Kristensen SD, Bøtker HE, Madsen M, Johnsen SP, Jensen LO, Sørensen HT, Thuesen L, Lassen JF; SORT OUT III study group. Rasmussen K, et al. Among authors: jensen lo, jensen js. Lancet. 2010 Mar 27;375(9720):1090-9. doi: 10.1016/S0140-6736(10)60208-5. Epub 2010 Mar 16. Lancet. 2010. PMID: 20231034 Clinical Trial.
829 results